Valerie Nadeau

Quebec, QC, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Identifying and Overcoming the Barriers to Virtual Electromyography Assessments: A Scoping Review.

Identifying and Overcoming the Barriers to Virtual Electromyography Assessments: A Scoping Review.

Journal: Telemedicine journal and e-health : the official journal of the American Telemedicine Association
Published: August 16, 2023

PARP1-PKM2 Axis Mediates Right Ventricular Failure Associated With Pulmonary Arterial Hypertension.

PARP1-PKM2 Axis Mediates Right Ventricular Failure Associated With Pulmonary Arterial Hypertension.

Journal: JACC. Basic to translational science
Published: October 21, 2021

Potential for inhibition of checkpoint kinases 1/2 in pulmonary fibrosis and secondary pulmonary hypertension.

Potential for inhibition of checkpoint kinases 1/2 in pulmonary fibrosis and secondary pulmonary hypertension.

Journal: Thorax
Published: March 30, 2021

Implication of EZH2 in the Pro-Proliferative and Apoptosis-Resistant Phenotype of Pulmonary Artery Smooth Muscle Cells in PAH: A Transcriptomic and Proteomic Approach.

Implication of EZH2 in the Pro-Proliferative and Apoptosis-Resistant Phenotype of Pulmonary Artery Smooth Muscle Cells in PAH: A Transcriptomic and Proteomic Approach.

Journal: International journal of molecular sciences
Published: February 18, 2021

Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension.

Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension.

Journal: International journal of molecular sciences
Published: February 16, 2021

Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension.

Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension.

Journal: American journal of respiratory and critical care medicine
Published: October 06, 2020

Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension.

Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension.

Journal: Circulation
Published: July 24, 2020

PIM1 (Moloney Murine Leukemia Provirus Integration Site) Inhibition Decreases the Nonhomologous End-Joining DNA Damage Repair Signaling Pathway in Pulmonary Hypertension.

PIM1 (Moloney Murine Leukemia Provirus Integration Site) Inhibition Decreases the Nonhomologous End-Joining DNA Damage Repair Signaling Pathway in Pulmonary Hypertension.

Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: January 24, 2020

Effect of p53 activation on experimental right ventricular hypertrophy.

Effect of p53 activation on experimental right ventricular hypertrophy.

Journal: PloS one
Published: January 20, 2020

Letter by Nadeau et al Regarding Article, "Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension".

Letter by Nadeau et al Regarding Article, "Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension".

Journal: Circulation
Published: August 13, 2019

Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart Disease.

Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart Disease.

Journal: Circulation research
Published: June 04, 2019

17β-Estradiol and estrogen receptor α protect right ventricular function in pulmonary hypertension via BMPR2 and apelin.

17β-Estradiol and estrogen receptor α protect right ventricular function in pulmonary hypertension via BMPR2 and apelin.

Journal: The Journal of clinical investigation
Published: April 08, 2019
Showing 1-12 of 29

Last Updated: 09/26/2026